These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 8962190)

  • 1. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergence of new therapeutic agents for collagen diseases and some of the problems].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leflunomide for therapy of rheumatoid arthritis].
    Nakajima A; Yamanaka H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405
    [No Abstract]   [Full Text] [Related]  

  • 6. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious liver disease in a patient receiving methotrexate and leflunomide.
    Weinblatt ME; Dixon JA; Falchuk KR
    Arthritis Rheum; 2000 Nov; 43(11):2609-11. PubMed ID: 11083289
    [No Abstract]   [Full Text] [Related]  

  • 9. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
    Sanders S; Harisdangkul V
    Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide for the treatment of rheumatoid arthritis.
    Olsen NJ; Strand V; Kremer JM
    Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculitis associated with the use of leflunomide.
    Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M
    J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 13. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide-associated tuberculosis?
    Hocevar A; Rozman B; Praprotnik S; Lestan B; Erzen D; Petric V; Tomsic M
    Rheumatology (Oxford); 2006 Feb; 45(2):228-9. PubMed ID: 16319103
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of leflunomide on immune responses and models of inflammation.
    Bartlett RR; Anagnostopulos H; Zielinski T; Mattar T; Schleyerbach R
    Springer Semin Immunopathol; 1993; 14(4):381-94. PubMed ID: 8322168
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual overdose of leflunomide in a patient with rheumatoid arthritis.
    Kamali S; Kasapoglu E; Uysal M; Inanc M; Gul A
    Ann Pharmacother; 2004; 38(7-8):1320-1. PubMed ID: 15138298
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 18. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract]   [Full Text] [Related]  

  • 19. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Herrmann ML; Schleyerbach R; Kirschbaum BJ
    Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
    Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.